Surmodics Reports Third Quarter Fiscal 2019 Results and Raises Fiscal 2019 Revenue and EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Surmodics Reports Third Quarter Fiscal 2019 Results and Raises Fiscal 2019 Revenue and EPS Guidance

SurModics (SRDX) Tops Q3 EPS by 10c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus

July 31, 2019 5:53 PM EDT

SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.15, $0.10 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.3 million versus the consensus estimate of $22.29 million.

Summary of Third Quarter and Recent Highlights

Revenue of $24.3 million, an increase of 9.5% year-over-yearGAAP EPS of $0.11, non-GAAP EPS of $0.15TRANSCEND clinical trial enrollment more than 90% complete

Our third... More